Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

University of Toronto

$120,000.00

Associations between comorbid type 2 diabetes mellitus and depression, peripheral apoptosis protein concentrations, and indicators of neurodegeneration.

FY 2025-26

Summary
Type 2 diabetes mellitus (T2DM) and depression are conditions which often co-occur, and individuals with both conditions are more likely to develop dementia than individuals with either condition alone. The reason for this remains largely unknown, and there are currently no treatments designed to prevent dementia specifically in people with both T2DM and depression. Animal studies have identified apoptosis, a process of programmed cell death, is related to depressive behaviours seen in T2DM rat models. Additionally, apoptosis has been associated with outcomes related to dementia, such as cognitive decline, brain volumes, and time to dementia diagnosis. However, apoptosis in relation to these outcomes has not been explored in humans with T2DM. Therefore, we will use participants from the UK Biobank and stratify them into four groups (healthy controls, depression only, T2DM only, T2DM with depression). We will first measure levels of several apoptosis-related proteins in their blood plasma and compare these levels between the four groups. We will also measure cognitive performance, 15-year dementia risk, regional brain volumes, and several imaging measures of the integrity of the brain's white matter. We will compare these outcomes between the four groups. Finally, we will compare the associations between the apoptosis protein levels and these neurological outcomes between the four groups. The presence of depression can affect activities of daily living and adherence to medication in T2DM, and the presence of dementia can make it worse. This study will identify apoptosis proteins associated with neurological outcomes related to dementia in T2DM and depression, potentially uncovering new targets for treatment in this especially high-risk group.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
559634
Name
Perfetto Sofia E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
DT2 (Health services and population health research) CGRS Doctoral
Projecttitle
Associations between comorbid type 2 diabetes mellitus and depression, peripheral apoptosis protein concentrations, and indicators of neurodegeneration.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Apoptosis; Cognitive Performance; Dementia; Depression; Neuroimaging; Plasma Proteomics; Type 2 Diabetes Mellitus
Abstract
Type 2 diabetes mellitus (T2DM) and depression are conditions which often co-occur, and individuals with both conditions are more likely to develop dementia than individuals with either condition alone. The reason for this remains largely unknown, and there are currently no treatments designed to prevent dementia specifically in people with both T2DM and depression. Animal studies have identified apoptosis, a process of programmed cell death, is related to depressive behaviours seen in T2DM rat models. Additionally, apoptosis has been associated with outcomes related to dementia, such as cognitive decline, brain volumes, and time to dementia diagnosis. However, apoptosis in relation to these outcomes has not been explored in humans with T2DM. Therefore, we will use participants from the UK Biobank and stratify them into four groups (healthy controls, depression only, T2DM only, T2DM with depression). We will first measure levels of several apoptosis-related proteins in their blood plasma and compare these levels between the four groups. We will also measure cognitive performance, 15-year dementia risk, regional brain volumes, and several imaging measures of the integrity of the brain's white matter. We will compare these outcomes between the four groups. Finally, we will compare the associations between the apoptosis protein levels and these neurological outcomes between the four groups. The presence of depression can affect activities of daily living and adherence to medication in T2DM, and the presence of dementia can make it worse. This study will identify apoptosis proteins associated with neurological outcomes related to dementia in T2DM and depression, potentially uncovering new targets for treatment in this especially high-risk group.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Perfetto, Sofia E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~